Company sustains high growth and profitability as biomedical industry adoption continue
s.
Framingham, MA, January 8, 2003 – clinivation, Inc. today announced record year-end revenue, growth, and profitability results for 2002.
“We are pleased to have achieved yet another year of record results, triple-digit growth and profitability,” said Joseph Kozikowski, M.D., clinivation’s Founder and Chief Executive Officer. “Our strong rates of growth and customer acquisition clearly support the value proposition of our next-generation infrastructure and productivity solutions,” he continued.
New sales to existing customers were also strong during the year, with additional contract orders coming from the medical device, diagnostics, and biopharmaceutical industry sectors.
“Our solutions accelerate our customers up the steepest segment of the medical product value creation curve. We expect demand for our solutions to continue to grow as companies seek to remedy margin-eroding pre-launch expenditures by adopting process-automating IT infrastructure and productivity solutions,” Dr. Kozikowski remarked.
About clinivation, Inc.
Clinivation is taking the time and labor out of commercializing your new medical products.
Our productivity applications and professional services easily fit into your existing business processes and enterprise infrastructure, and are used by market leaders in medical devices, pharmaceuticals, and diagnostics.
